Most Anticipated Drug Launches of 2023

Letting new drugs into the market is never easy, so only a few entries get passed the strict FDA regulations annually.  Those that do pass, though, have the potential to enrich the current drug market and make it easier for both physicians and patients to get the most out of treatments.  Regarding the types of […]

Novel FDA Drug Approvals in 2022

Coming up with a new drug that can help save lives or at least alleviate the symptoms of patients worldwide is a noble pursuit with a tough road ahead.  Getting a drug approved is justifiably rigorous and arduous, as the lives of people taking the drugs can get significantly affected by them – for better […]

Sustainability in Pharma: How Does it Measure Up?

No expense is too high to test, develop, and distribute a drug thoroughly. After all, we are talking about the health and well-being of humans.  Despite the appearance of drugs as small, easy to mass produce, and relatively inexpensive, developing, testing, and making a drug takes a lot of time, resources, and energy.  As more […]

Vigilant Biosciences Announces Agreement with Eurobio for Exclusive Distribution of the OncAlert™ Oral Cancer Risk Assessment System in France, Algeria, Morocco and Tunisia

Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive sales and marketing agreement with Eurobio for the distribution of the OncAlert Oral Cancer Risk Assessment System in France, Algeria, Morocco and Tunisia. The […]

First Biogen Inc, Now Roche Holding Ltd. : Rays Of Hope For An Alzheimer’s Cure

After Biogen’s success in slowing down Alzheimer’s progress in early-stage trials, Roche Holding intends to take its own Alzheimer’s candidate on a trial re-run Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) is considering the initiation of a second trial to test its investigational Alzheimer’s drug that was abandoned in December after a disappointing initial study, Bloomberg reports. […]

FDA Advisory Panel Approves Flibanserin, Experimental ‘Viagra For Women’

Flibanserin is being hailed as “Viagra for women.” The experimental drug – designed for post-menopausal women with low sex drives – has now won approval from an advisory panel for the Food and Drug Administration (FDA). The FDA previously rejected the female libido pill twice since 2010 over concerns of side effects. In 2005, an […]

Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of adult patients with chronic hepatitis C genotypes (GT) 1, 4 or […]

Biomedical Research: Diagnosis of Deputies

The law N° 28-13, introduced in June 2014, was finally adopted by the chamber of deputies. The impact of this new legislation on the development of biomedical research was highlighted by the committee of social sectors. Members have declared the gap in the law that has long prevailed in this area and has negatively impacted […]

Regeneron (REGN), Sanofi (SNY) Announce Sarilumab Met co-Primary Endpoints in Phase 3

Regeneron (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo. The study, called SARIL-RA-TARGET, evaluated the […]

Poseidon CRO Celebrating International Clinical Trials Day

International Clinical Trials Day is celebrated around the world on or near the 20 May each year, to commemorate the day that James Lind started his famous trial on the deadly disease scurvy in 1747.It provides a focal point to raise awareness of the importance of research to health care. Poseidon CRO , is happy […]

Retina Implant’s Global Study of the Alpha Ims Microchip Published in Vision Research

Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced the publication of data from the Company’s global clinical trial involving seven sites across five countries. The study, published in the May 2015 edition of the peer-reviewed journal Vision Research, presents the visual results of 29 late-stage […]

New Drug Combination Could Extend Life of Cystic Fibrosis Patients

An international research team has demonstrated that a combination of two different drugs targeting the most common genetic cause of cystic fibrosis helped to improve lung function and reduce the rate of pulmonary exacerbations. “These results represent a further major advance in finding treatments which correct the basic problem in cystic fibrosis and improve the […]